These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5292809)

  • 41. Antidyskinetic Effect of 7-Nitroindazole and Sodium Nitroprusside Associated with Amantadine in a Rat Model of Parkinson's Disease.
    Bortolanza M; Bariotto-Dos-Santos KD; Dos-Santos-Pereira M; da-Silva CA; Del-Bel E
    Neurotox Res; 2016 Jul; 30(1):88-100. PubMed ID: 27053252
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Amantadine in the therapy of Parkinson syndromes].
    Pfaff G
    Med Klin; 1980 Oct; 75(22):792-4. PubMed ID: 7453628
    [No Abstract]   [Full Text] [Related]  

  • 43. Treating the progressive stages of Parkinson's disease.
    Varon J; Jacobs MB
    Postgrad Med; 1991 Jul; 90(1):63-6, 69-71. PubMed ID: 1905807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
    Sigwald J; Raymondeaud C; Piot C
    Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
    [No Abstract]   [Full Text] [Related]  

  • 45. Parkinson's disease.
    Lieberman AN
    Compr Ther; 1986 Mar; 12(3):25-9. PubMed ID: 3486090
    [No Abstract]   [Full Text] [Related]  

  • 46. In practice. Parkinson's disease.
    Hill JW
    N Z Med J; 1979 Oct; 90(645):300-4. PubMed ID: 229444
    [No Abstract]   [Full Text] [Related]  

  • 47. Therapeutic uses and side effects of L-dopa.
    Boshes B
    Adv Intern Med; 1972; 18():219-49. PubMed ID: 4576081
    [No Abstract]   [Full Text] [Related]  

  • 48. The treatment with L-dopa and amantadine in Parkinson's disease.
    Pendefunda G; Pollingher B; Stefanache F; Gavril A; Oprisan C; Merling M; Nemteanu E; Ciunru M; Koropitzer I
    Ther Hung; 1975; 23(1):12-6. PubMed ID: 1105871
    [No Abstract]   [Full Text] [Related]  

  • 49. [Amantadine therapy in parkinsonism].
    Pakkenberg H
    Ugeskr Laeger; 1973 Jan; 135(3):135-6. PubMed ID: 4685048
    [No Abstract]   [Full Text] [Related]  

  • 50. [Therapy of Parkinson's syndrome].
    Gehlen W
    Dtsch Med Wochenschr; 1986 Aug; 111(31-32):1208-10. PubMed ID: 3525083
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment for Parkinsonism, other than levodopa.
    Br Med J; 1972 Mar; 1(5802):741-2. PubMed ID: 5015332
    [No Abstract]   [Full Text] [Related]  

  • 52. Advances in the management of parkinson's disease.
    Marsden CD
    Scott Med J; 1976 Jul; 21(3):139-48. PubMed ID: 781839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. L-dopa and amantadine hydrochloride in Parkinson's disease.
    Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417
    [No Abstract]   [Full Text] [Related]  

  • 54. The effect of adding amantadine to optimum L-dopa dosage in Parkinson's syndrome.
    Fehling C
    Acta Neurol Scand; 1973; 49(2):245-51. PubMed ID: 4577929
    [No Abstract]   [Full Text] [Related]  

  • 55. [Amantadine therapy in Parkinsonism].
    Forssman B; Kihlstrand S; Larsson LE
    Lakartidningen; 1972 Mar; 69():55-9. PubMed ID: 4577428
    [No Abstract]   [Full Text] [Related]  

  • 56. Medical therapy of Parkinsonism.
    Yahr MD; Duvoisin RC
    Mod Treat; 1968 Mar; 5(2):283-300. PubMed ID: 5655945
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical effects of L-dopa in Parkinson's disease].
    Fasano VA
    Sist Nerv; 1970; 22(2):119-23. PubMed ID: 5504550
    [No Abstract]   [Full Text] [Related]  

  • 58. [Therapy of parkinsonism].
    Oftedal SI
    Tidsskr Nor Laegeforen; 1969 Apr; 89(7):489-91. PubMed ID: 5794674
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)].
    Schneider E; Fischer PA; Jacobi P
    Med Klin; 1974 Mar; 69(13):541-5. PubMed ID: 4831456
    [No Abstract]   [Full Text] [Related]  

  • 60. Interactions of L-dopa and amantadine in patients with Parkinsonism.
    Cox B; Danta G; Schnieden H; Yuill GM
    J Neurol Neurosurg Psychiatry; 1973 Jun; 36(3):354-61. PubMed ID: 4714097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.